Introduction
There are over 125 million pregnant women at risk of malaria. The majority (40 million) of these are at risk of Plasmodium vivax (P. vivax) and 32 million are at risk of Plasmodium falciparum (P. falciparum), and 53 million are at risk of co-infection of both P. vivax and P. falciparum [1] . Pregnant women are at increased risk, density and multiplicity of P. vivax infections than the non-pregnant ones [2] [3] [4] [5] [6] .
In malaria endemic areas (especially areas of low malaria transmission), both P. falciparum and P. vivax infections have adverse effects on placental development and fetal outcomes [7] [8] [9] . It has been reported that compared to non-infected pregnant women, P. vivax-infected pregnant women were at higher risk of anemia and have lower birth weights in babies [2, 10, 11] .
In sub-Saharan Africa (including Sudan), where the vast majority of malaria infections are due to P. falciparum, the placental infections and the adverse pregnancy outcomes have been extensively studied including epidemiology, anemia and low birth weight [12] [13] [14] [15] .
In sub-Saharan Africa, the paradigm of the Duffy antigen dependence for P. vivax and the benign character formerly attributed to P. vivax infection were challenged by the increasing number of reports of P. vivax in the blood of Duffy-negative individuals and severe disease associated with P. vivax infection [16] [17] [18] [19] . There are few published data (especially in Africa) on P. vivax infection during pregnancy and no published data on P. vivax infection during pregnancy in Sudan [20, 21] . This study was conducted to determine the epidemiology of malaria (especially P. vivax) among pregnant women in Eastern Sudan. characterized by unstable malaria transmission. P. falciparum was the main species encountered in the area [22] . However, in the last few years, P. vivax infections were reported and even severe cases of P. vivax were observed [19] . After signing an informed consent from both the cases of malaria and healthy controls, obstetrics and medical (age, parity, gestational age) history were gathered using questionnaire. The women's weight and axillary temperature were recorded. The data of pregnant women who had malaria infection (P. vivax/P. falciparum) and healthy controls women were recorded. The hemoglobin was measured. Women with malaria were treated with artesunate sulfadoxine-pyrimethamine which is the first line treatment for malaria in Sudan [23] .
Materials and methods

Blood smears for malaria and light microscopy
The blood smears were prepared as described in the previous work [13] . In summary, thick and thin blood films were prepared and stained with 10% Giemsa and examined under the 100 oil-immersion objective lens of a light microscope. The asexual parasites density was counted per 200 leukocytes assuming a leukocyte count of 8 000 leukocytes/μL (for thick films) or per 1 000 red blood cells (for thin films). Blood films were considered negative if no parasites were detected in 100 oil-immersion fields of a thick blood film.
Statistics
The data were entered into computer using SPSS for Windows. The mean ± SD of the medical and obstetrical variables (age, parity, gestational age, weight, hemoglobin) was compared between the women in the three groups (P. vivax, P. falciparum and healthy controls) using One-way ANOVA with Post-hoc Bonferroni analyses. The parasite count was compared between women with P. vivax and P. falciparum malaria by non-parametric test.
Ethics
The study protocol was performed according to the Helsinki declaration and approved by Research Board at the Department of Obstetrics and Gynecology, Faculty of Medicine, University of Khartoum, Sudan. Informed written consent was obtained from Ministry of Health, Kassala, Sudan.
Results
A total of 2 378 women attended the antenatal clinic during the study period. Out of these, there were 48 (2.0%) and 36 (1.5%) P. falciparum and P. vivax infection, respectively (ratio = 1.3:1.0). There was no P. falciparum and P. vivax co-infection. There was no significant difference in the age, parity, gestational age between women with malaria and healthy controls (Table 1) . All values were expressed as mean ± SD. -: Absent.
The mean ± SD of the temperature was significantly higher in patients with P. vivax compared with patients with P. falciparum malaria [(38.6 ± 0.7) °C vs. (38.1 ± 0.6) °C , P = 0.001].
Patients with P. vivax malaria had slightly (not reach statistical significance) lower hemoglobin level compared with P. falciparum malaria and healthy controls (Table 1) .
There was no significant difference in the geometric parasite count between patients with P. vivax and P. falciparum malaria infections (12 189.9 vs. 9 755.1 trophozoite/µL, P = 0.356) (Figure1). 
Discussion
This is the first report of P. vivax malaria infections among pregnant women in Sudan. The previous reports have shown that P. falciparum was the sole species among pregnant women in the Eastern and Central Sudan [13, 15, 24] . It has recently been shown that P. vivax malaria is an existing health problem and even severe cases of P. vivax were observed among both children and adults in Eastern Sudan [18, 19] . The influx of the Ethiopians through the border after signing the peace agreement was the explanation mentioned by some researchers [18] . There are generally few reports of P. vivax infections among pregnant women in Africa and P. vivax was considered rare before [20, 21] .
In the current study, there was no significant difference in the mean age and parity between pregnant women with P. falciparum and P. vivax infections, and healthy controls women. This goes with the previous reports where it has been shown that pregnant women in Eastern and Central Sudan were susceptible to P. falciparum infections regardless to their age and parity, and the low transmission of the malaria infections in the area was the main explanation. On the other hand, primigravidae were observed to have an increased risk of P. falciparum and P. vivax compared to multigravidae [25] .
Interestingly, in this study, women with P. vivax malaria had significantly higher temperature than women with P. falciparum malaria. This goes with previous studies that showed that P. vivax had a lower pyrogenic threshold and cytokines released compared to P. falciparum [26] [27] [28] . Fever as well as the other clinical consequences of Plasmodium infection are manifest during the blood-stage of infection and are worsened by high densities of the parasitemia. The lower pyrogenic threshold and densities of the parasitemia could be explained by the ability of P. falciparum to invade all erythrocytes, whereas P. vivax selectively infests young erythrocytes (reticulocytes), and thus P. vivax could have a lower parasitemia than P. falciparum [29, 30] .
Limitations of the present study
The study was small size and might lack the power to estimate the difference between the P. vivax and P. falciparum malaria. Only blood smears were performed to diagnose parasitaemia and PCR was not performed and women were not followed-up to further investigate the placentas and the pregnancy outcome.
